# Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia

> **NCT03015532** · PHASE2 · COMPLETED · sponsor: **Heron Therapeutics** · enrollment: 285 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** HTX-011
- **DRUG:** Saline Placebo
- **DRUG:** Bupivicaine HCl
- **DRUG:** Ropivacaine

## Key facts

- **NCT ID:** NCT03015532
- **Lead sponsor:** Heron Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-13
- **Primary completion:** 2018-04-20
- **Final completion:** 2018-05-16
- **Target enrollment:** 285 (ACTUAL)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03015532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03015532, "Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03015532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*